|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This site is Private and is used only for training new Angel Editors, Bloggers & Columnists! | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
3/20/10Care for clinical trial participants may be expanded
(Posted By: Josi Creek)
HARTFORD — The General Assembly’s Insurance and Real Estate Committee this week approved bills that expand coverage of routine care costs for patients who participate in certain clinical trials and change requirements for disclosing records. Sen. Joseph J. Crisco Jr., D-Woodbridge, said one piece of legislation would help patients who stand to be denied coverage through their health insurance provider. Managed care organizations, health insurers or utilization review companies are not required to disclose all records on how a decision was reached for denial. Senate Bill 258, An Act Concerning Appeals of Health Insurance Benefits Denials, would require that records be disclosed upon the patient’s request. A separate piece of legislation, Senate Bill 260, An Act Concerning Health Insurance Coverage for Routine Patient Care Costs for Clinical Trial Patients, would expand coverage of routine costs for those participating in clinical trials on multiple sclerosis and Parkinson’s disease. Read the full story, at the New Haven Register here. |
Post a Comment